Ikarian Capital »

Aethlon Med shares owned by Ikarian Capital

Quarter-by-quarter ownership of Aethlon Med (AEMD) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Aethlon Med

Tip: Access up to 7 years of quarterly data

All positions including Aethlon Med held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aethlon Med by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $115k 154k 0.75
2025-06-30 $184k 154k 1.20

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Aethlon Med

Ikarian Capital
Hrt Financial
Citadel Advisors
Renaissance Technologies
Scientech Research
Two Sigma Investments
XTX Topco
Two Sigma Securities
Geode Capital Management
Tower Research Capital
Morgan Stanley
Group One Trading
BlackRock
Wells Fargo & Company
Advisor Group Holdings

View all funds holding Aethlon Med